Novavax (NVAX)

Novavax (NVAX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• NVAX last traded at $9.65, -4.27% on the day.
• Novavax: market cap $1.66B, P/E -6.3, revenue $413.80M over the last four quarters, next earnings 2026-11-05.
• Over the past year NVAX returned 14.47%; year to date 43.60%.

Updated 2026-11-02 19:29 UTC